Fulton Bank, N.A. Gilead Sciences, Inc. Transaction History

Fulton Bank, N.A.

$1.12 Billion
Q2 2024

A detailed history of Fulton Bank, N.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fulton Bank, N.A. holds 32,500 shares of GILD stock, worth $2.75 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

32,500

Previous 31,493 3.2%

Holding current value

$2.75 Million

Previous $2.31 Million 3.34%

% of portfolio

0.2%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$63.15 - $72.88 $63,592 - $73,390	1,007 Added 3.2%	32,500 $2.23 Million
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $914,434 - $1.12 Million	12,775 Added 68.25%	31,493 $2.31 Million
Q4 2023 Jan 04, 2024	SELL	$73.27 - $83.09 $12,529 - $14,208	-171 Reduced 0.91%	18,718 $1.52 Million
Q3 2023 Oct 04, 2023	BUY	$73.94 - $80.67 $50,131 - $54,694	678 Added 3.72%	18,889 $1.42 Million
Q2 2023 Jul 06, 2023	SELL	$76.01 - $86.7 $814,067 - $928,557	-10,710 Reduced 37.03%	18,211 $1.4 Million
Q1 2023 Apr 06, 2023	SELL	$77.31 - $88.08 $2.31 Million - $2.63 Million	-29,866 Reduced 50.8%	28,921 $2.4 Million
Q4 2022 Jan 05, 2023	SELL	$62.32 - $89.47 $37,267 - $53,503	-598 Reduced 1.01%	58,787 $5.05 Million
Q3 2022 Oct 04, 2022	BUY	$59.54 - $68.01 $42,332 - $48,355	711 Added 1.21%	59,385 $3.66 Million
Q2 2022 Jul 07, 2022	BUY	$57.72 - $65.01 $382,741 - $431,081	6,631 Added 12.74%	58,674 $3.63 Million
Q1 2022 Apr 05, 2022	BUY	$57.92 - $72.58 $423,916 - $531,213	7,319 Added 16.36%	52,043 $3.09 Million
Q4 2021 Jan 05, 2022	SELL	$64.88 - $73.64 $44,507 - $50,517	-686 Reduced 1.51%	44,724 $3.25 Million
Q3 2021 Oct 05, 2021	SELL	$67.69 - $73.03 $43,389 - $46,812	-641 Reduced 1.39%	45,410 $3.17 Million
Q2 2021 Jul 06, 2021	SELL	$63.47 - $69.35 $148,138 - $161,862	-2,334 Reduced 4.82%	46,051 $3.17 Million
Q1 2021 Apr 05, 2021	SELL	$60.0 - $68.46 $382,800 - $436,774	-6,380 Reduced 11.65%	48,385 $3.13 Million
Q4 2020 Jan 07, 2021	BUY	$56.65 - $64.55 $640,314 - $729,608	11,303 Added 26.01%	54,765 $3.19 Million
Q3 2020 Oct 06, 2020	BUY	$62.1 - $78.08 $1.29 Million - $1.63 Million	20,825 Added 92.0%	43,462 $2.75 Million
Q2 2020 Jul 06, 2020	SELL	$72.34 - $84.0 $3.39 Million - $3.93 Million	-46,805 Reduced 67.4%	22,637 $1.74 Million
Q1 2020 Apr 03, 2020	BUY	$62.63 - $80.22 $158,641 - $203,197	2,533 Added 3.79%	69,442 $5.19 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $5,237 - $5,761	85 Added 0.13%	66,909 $4.35 Million
Q3 2019 Oct 03, 2019	BUY	$62.51 - $69.0 $1.94 Million - $2.14 Million	31,050 Added 86.79%	66,824 $4.24 Million
Q2 2019 Jul 03, 2019	SELL	$61.87 - $69.38 $160,305 - $179,763	-2,591 Reduced 6.75%	35,774 $2.42 Million
Q1 2019 Apr 03, 2019	SELL	$62.53 - $70.05 $239,865 - $268,711	-3,836 Reduced 9.09%	38,365 $2.49 Million
Q4 2018 Jan 03, 2019	SELL	$60.54 - $79.0 $496,004 - $647,247	-8,193 Reduced 16.26%	42,201 $2.64 Million
Q3 2018 Oct 03, 2018	SELL	$71.28 - $78.92 $486,699 - $538,865	-6,828 Reduced 11.93%	50,394 $3.89 Million
Q2 2018 Jul 10, 2018	BUY	$64.88 - $75.68 $2,724 - $3,178	42 Added 0.07%	57,222 $4.05 Million
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $579,879 - $706,936	7,961 Added 16.17%	57,180 $4.31 Million
Q4 2017 Jan 04, 2018	SELL	$71.15 - $83.52 $66,738 - $78,341	-938 Reduced 1.87%	49,219 $3.53 Million
Q3 2017 Oct 04, 2017	BUY	$72.11 - $85.47 $3.62 Million - $4.29 Million	50,157	50,157 $4.06 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account